Skip to main content
Premium Trial:

Request an Annual Quote

NanoString Technologies Secures $15M Senior Credit Facility

NEW YORK (GenomeWeb News) – NanoString Technologies has received $15 million in debt financing from Oxford Finance and Silicon Valley Bank.

The financing includes a $13 million senior secured term loan and a $2 million revolving line of credit and will be used to fund NanoString's growth and for working capital.

Based in Seattle, NanoString is developing a breast cancer assay based on expression of the PAM50 gene signature. It also makes the nCounter Analysis System, a fully automated digital gene expression tool that can multiplex hundreds of genes per sample and detect and count single molecules.

"This facility further strengthens NanoString's balance sheet, allowing us to continue growing our core life sciences business while aggressively pursuing the diagnostics opportunity," Wayne Burns, CFO of NanoString, said in a statement.

NanoString raised $20 million in a Series D round in November.

The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.